- Home
- EVF vs HLVX Comparison
EVF vs HLVX Comparison
Compare EVF & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVF
- HLVX
- Stock Information
- Founded
- EVF 1998
- HLVX 2020
- Country
- EVF United States
- HLVX United States
- Employees
- EVF N/A
- HLVX N/A
- Industry
- EVF Investment Managers
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- EVF Finance
- HLVX Health Care
- Exchange
- EVF Nasdaq
- HLVX Nasdaq
- Market Cap
- EVF 101.0M
- HLVX 104.3M
- IPO Year
- EVF N/A
- HLVX 2022
- Fundamental
- Price
- EVF $5.51
- HLVX $2.09
- Analyst Decision
- EVF
- HLVX Hold
- Analyst Count
- EVF 0
- HLVX 1
- Target Price
- EVF N/A
- HLVX $2.00
- AVG Volume (30 Days)
- EVF 93.3K
- HLVX 714.8K
- Earning Date
- EVF 01-01-0001
- HLVX 11-06-2025
- Dividend Yield
- EVF 10.68%
- HLVX N/A
- EPS Growth
- EVF N/A
- HLVX N/A
- EPS
- EVF 0.94
- HLVX N/A
- Revenue
- EVF N/A
- HLVX N/A
- Revenue This Year
- EVF N/A
- HLVX N/A
- Revenue Next Year
- EVF N/A
- HLVX N/A
- P/E Ratio
- EVF $6.74
- HLVX N/A
- Revenue Growth
- EVF N/A
- HLVX N/A
- 52 Week Low
- EVF $5.20
- HLVX $1.34
- 52 Week High
- EVF $6.84
- HLVX $2.17
- Technical
- Relative Strength Index (RSI)
- EVF 38.47
- HLVX 52.97
- Support Level
- EVF $5.54
- HLVX $2.07
- Resistance Level
- EVF $5.58
- HLVX $2.11
- Average True Range (ATR)
- EVF 0.04
- HLVX 0.03
- MACD
- EVF 0.00
- HLVX -0.00
- Stochastic Oscillator
- EVF 35.40
- HLVX 41.67
About EVF Eaton Vance Senior Income Trust
Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.